Showing results (1-10 of 576) with videos related to

Sort By:
Pageof 58
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 23, 2025
Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort StudyXinyi Sun, James Heyward, Joseph C Murray, et al.
JAMA Oncology|May 8, 2025
Harm-Benefit Balance of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerJames Heyward, Catherine R Lesko, Joseph C Murray, et al.
Pharmacoepidemiology and Drug Safety|August 5, 2024
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)Xuya Xiao, G Caleb Alexander, Hemalkumar B Mehta
Journal of Diabetes and Metabolic Disorders|January 9, 2026
Treatment of type 2 diabetes among medicare beneficiaries with and without alzheimer's disease: A retrospective cohort studyYingqi Wang, G Caleb Alexander, Hemalkumar B Mehta
Psychiatric Services (Washington, D.C.)|August 26, 2020
Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for PimavanserinHemalkumar B Mehta, Thomas J Moore, G Caleb Alexander
Journal of the American Medical Directors Association|October 6, 2024
Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort StudyHemalkumar B Mehta, Xuya Xiao, Huijun An, et al.
Plos Medicine|September 26, 2025
Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort studyJingjing Sun, Hemalkumar B Mehta, Jodi B Segal, et al.
Clinical and Translational Science|October 21, 2020
Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United StatesJames M Stevenson, G Caleb Alexander, Natasha Palamuttam, et al.
Pharmacotherapy|August 4, 2023
Potential drug-drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross-sectional study of the National Covid Cohort Collaborative (N3C)Xuya Xiao, Hemalkumar B Mehta, Jill Curran, et al.
Pharmacoepidemiology and Drug Safety|February 17, 2025
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer PopulationJames S Heyward, Jodi B Segal, Hemalkumar B Mehta, et al.
Pageof 58